IN-SITU HYBRIDIZATION ON MAY-GRUNWALD GIEMSA STAINED BONE-MARROW AND BLOOD SMEARS OF PATIENTS WITH HEMATOLOGIC DISORDERS ALLOWS DETECTION OF CELL-LINEAGE SPECIFIC CYTOGENETIC ABNORMALITIES
K. Vanlom et al., IN-SITU HYBRIDIZATION ON MAY-GRUNWALD GIEMSA STAINED BONE-MARROW AND BLOOD SMEARS OF PATIENTS WITH HEMATOLOGIC DISORDERS ALLOWS DETECTION OF CELL-LINEAGE SPECIFIC CYTOGENETIC ABNORMALITIES, Blood, 82(3), 1993, pp. 884-888